Surfing the MASH Tsunami

S4-E34.1 - The Excitement of FASN Inhibitors: Positive 2B Interim Data for Denifanstat

29 Jul 2023

Contributed by Lukas

Send a textThis month, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from June's two major conferences: the 2023 E...

S4-E34 - Drug Development Stories from EASL and ADA: Part 2

27 Jul 2023

Contributed by Lukas

Send a textThis month, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from June's two major conferences: the 2023 E...

S4-E33.5 - From the Vault: ILC 2022 Looking Back: NASH Is a Complex Disease

23 Jul 2023

Contributed by Lukas

Send a textThe first three days of the 2022 program focused on a range of issues, with specific emphasis on non-invasive tests (NITs) and their role a...

S4-E33.4 - More Presentation Insights on Frequency of Testing, NITs and Biopsy

23 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E33.3 - Steatotic Liver Disease, HCC and Mechanisms of Fibrosis Resolution

22 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E33.2 - Unmet Needs in the Primary Care Setting for Disease Identification

22 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E33.1 - EASL Congress 2023: Focus on New Nomenclature

22 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E33 - EASL Congress: Nomenclature and More Compelling Presentations

20 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E32.5 - From the Vault: ILC 2022 Looking Back: Crystal Balling & The Semaglutide Trial

17 Jul 2023

Contributed by Lukas

Send a textIn 2022, roughly 5,000 liver community stakeholders gathered in London for the 2022 International Liver Congress (#ILC2022,) the first majo...

S4-E32.4 - The Potential of NASH Drugs as Adjuvant Therapy

16 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E32.3 - Discussing Other Drugs in the Therapeutic Landscape

15 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E32.2 - Why We Should Develop Deeper Understanding of Liver Volume

15 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E32.1 - Lead Principle Investigator Stephen Harrison Recaps the MAESTRO-NASH Program for Resmetirom

15 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E32 - Drug Development Stories from EASL and ADA: Part 1

13 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both t...

S4-E31.4 - EASL Congress and ADA Scientific Sessions: Reshaping the way we think about Fatty Liver Disease

09 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at bo...

S4-E31.3 - Jörn Schattenberg on the Therapeutic Landscape and Fibrosis Resolution

09 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at bo...

S4-E31.2 - What do we know about mechanisms of action in NASH drugs and the commercial implications?

09 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at bo...

S4-E31.1 - Mazen Noureddin on "NASH Monopoly"

09 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at bo...

S4-E31 - Mazen Noureddin and Jörn Schattenberg on the Developing Therapeutic Landscape

07 Jul 2023

Contributed by Lukas

Send a textThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy last few weeks at b...

S4-E30.4 - EASL Congress 2023: Final Takeaways

02 Jul 2023

Contributed by Lukas

Send a textSurfing NASH delivered a second wrap-up session on-site in Vienna as a part of its real-time coverage of a truly thought-provoking EASL Con...

S4-E30.3 - EASL Congress 2023: More Posters and Presentations

02 Jul 2023

Contributed by Lukas

Send a textSurfing NASH delivered a second wrap-up session on-site in Vienna as a part of its real-time coverage of a truly thought-provoking EASL Con...

S4-E30.2 - EASL Congress 2023: Scoring Systems to Evaluate NASH

02 Jul 2023

Contributed by Lukas

Send a textSurfing NASH delivered a second wrap-up session on-site in Vienna as a part of its real-time coverage of a truly thought-provoking EASL Con...

S4-E30.1 - EASL Congress 2023: Nomenclature Rollout

02 Jul 2023

Contributed by Lukas

Send a textSurfing NASH delivered an additional wrap-up session on-site in Vienna as a part of its real-time coverage of a truly thought-provoking EAS...

S4-E29.3 - EASL Congress 2023: Final Thoughts on Days 1-3

01 Jul 2023

Contributed by Lukas

Send a textSurfing NASH offered on-site coverage of EASL Congress 2023 in two separate real-time reviews. This conversation features the final session...

S4-E29.2 - EASL Congress 2023: Challenges in Patient Screening and the “2nd Wave” of NASH Therapeutics

01 Jul 2023

Contributed by Lukas

Send a textSurfing NASH offered on-site coverage of EASL Congress 2023 in two separate real-time reviews. This conversation continues from the first s...

S4-E29.1 - EASL Congress 2023: Presentation on MAESTRO-NASH Phase 3 Results

01 Jul 2023

Contributed by Lukas

Send a textSurfing NASH offered on-site coverage of EASL Congress 2023 in two separate real-time reviews. This conversation comes from the first sessi...

S4-E30 - EASL Congress 2023: Real-Time Review Part 2

26 Jun 2023

Contributed by Lukas

Send a textSurfing NASH  delivers another wrap-up session on-site in Vienna in a real-time review of a truly thought-provoking EASL Congress 2023. Th...

S4-E29 - EASL Congress 2023: Real-Time Review Part 1

26 Jun 2023

Contributed by Lukas

Send a textSurfing NASH  delivers a session on-site in Vienna to offer a real-time review as EASL Congress 2023 unfolds. This first of two on-site re...

S4-E28 - Tetiana Deshko on the public health care in Ukraine during the invasion

22 Jun 2023

Contributed by Lukas

Send a textFor the first time in the 198-episode history of this podcast, Surfing NASH will not be hosting a discussion centered around NAFLD, NASH, s...

S4-E27.6 - Deep Dive into AI and Pathology with Arun Sanyal and David Kleiner

18 Jun 2023

Contributed by Lukas

Send a textSurfing NASH serves yet another preview of a highly anticipated and upcoming EASL Congress in Vienna, this time focusing on a strong lineup...

S4-E27.5 - EASL Congress 2023: Exploring Technology for Identifying Patients

18 Jun 2023

Contributed by Lukas

Send a textSurfing NASH extends its preview coverage of the upcoming EASL Congress with a three-part episode. This final conversation with Louise Camp...

S4-E27.4 - Previewing EASL Congress 2023 with Louise Campbell: Frontline Screening

18 Jun 2023

Contributed by Lukas

Send a textSurfing NASH extends its preview coverage of the upcoming EASL Congress with a three-part episode. This conversation continues on the theme...

S4-E27.3 - Abstract session - NAFLD: Clinical Aspects

17 Jun 2023

Contributed by Lukas

Send a textSurfing NASH extends its preview coverage of the upcoming EASL Congress with a three-part episode. This conversation comes from our final s...

S4-E27.2 - Abstract session - NAFLD: Therapy

17 Jun 2023

Contributed by Lukas

Send a textSurfing NASH extends its preview coverage of the upcoming EASL Congress with a three-part episode. This conversation continues to unpack th...

S4-E27.1 - Unpacking the Program with Ian Rowe and Jörn Schattenberg

17 Jun 2023

Contributed by Lukas

Send a textSurfing NASH extends its preview coverage of the upcoming EASL Congress with a three-part episode. First up, Ian Rowe and Jörn Schattenber...

S4-E27 - EASL Congress 2023 Preview: Great Talks to Anticipate!

15 Jun 2023

Contributed by Lukas

Send a textSurfing NASH serves yet another preview of a highly anticipated and upcoming EASL Congress in Vienna, this time focusing on a strong lineup...

S4-E25.5 - Wrap-Up on NICE Guidance for FibroScan

12 Jun 2023

Contributed by Lukas

Send a textIn a monumental moment for combatting Fatty Liver disease, NICE has published the much anticipated evidence-based recommendations on FibroS...

S4-E25.4 - NICE Guidance for FibroScan: The Devil is in the Details

12 Jun 2023

Contributed by Lukas

Send a textIn a monumental moment for combatting Fatty Liver disease, NICE has published the much anticipated evidence-based recommendations on FibroS...

S4-E25.3 - The Future of FibroScan and Optimizing Availability of Quality Scanning

12 Jun 2023

Contributed by Lukas

Send a textIn a monumental moment for combatting Fatty Liver disease, NICE has published the much anticipated evidence-based recommendations on FibroS...

S4-E25.2 - NICE Guidance for FibroScan: Collecting Data Well and Wisely

11 Jun 2023

Contributed by Lukas

Send a textIn a monumental moment for combatting Fatty Liver disease, NICE has published the much anticipated evidence-based recommendations on FibroS...

S4-E25.1 - Meeting Vanessa Hebditch and the Role of the British Liver Trust in Fighting for FibroScan

11 Jun 2023

Contributed by Lukas

Send a textIn a monumental moment for combatting Fatty Liver disease, NICE has published the much anticipated evidence-based recommendations on FibroS...

S4-E26.4 - International #NASHDay 2023 Wrap-Up

11 Jun 2023

Contributed by Lukas

Send a textThursday, June 8 was International #NASHDay 2023 and the podcast hosted a special session featuring patient advocates Gina Villiotti Madiso...

S4-E26.3 - FibroScan and the Impact of Socioeconomic Factors on Liver Health

10 Jun 2023

Contributed by Lukas

Send a textThursday, June 8 was International #NASHDay 2023 and the podcast hosted a special session featuring patient advocates Gina Villiotti Madiso...

S4-E26.2 - Discussing the Rise of NAFLD/NASH in Adolescents

10 Jun 2023

Contributed by Lukas

Send a textThursday, June 8 was International #NASHDay 2023 and the podcast hosted a special session featuring patient advocates Gina Villiotti Madiso...

S4-E26.1 - What Patient Advocate Organizations Are Doing Around the World in Support of #NASHDay 2023

10 Jun 2023

Contributed by Lukas

Send a textThursday, June 8 was International #NASHDay 2023 and the podcast hosted a special session featuring patient advocates Gina Villiotti Madiso...

S4-E26 - Patient Advocate Focus on International #NASHDay 2023

09 Jun 2023

Contributed by Lukas

Send a textThursday, June 8 was International #NASHDay 2023 and the podcast hosted a special session featuring patient advocates Gina Villiotti Madiso...

S4-E25 - Exciting News! NICE Guidance Supports FibroScan Use Outside Secondary and Specialist Care in the UK

08 Jun 2023

Contributed by Lukas

Send a textIn a monumental moment for combatting Fatty Liver disease, NICE has published the much anticipated evidence-based recommendations on FibroS...

S4-E24.6 - From the Vault: Did the Innovations in NAFLD Care Conference Strengthen the Case for an Integrated NAFLD Care Pathway?

04 Jun 2023

Contributed by Lukas

Send a textOn May 6 and 7 2022, over 100 NAFLD stakeholders convened in Barcelona and on-line for the inaugural Innovations in NAFLD Care 2022 confere...

S4-E24.5 - INCBCN Review: Wrap-Up Comments and Moving Forward

04 Jun 2023

Contributed by Lukas

Send a textSurfing NASH returns to review the 2023 Innovations in NAFLD Care Workshop (INCBCN) which concluded on 27 May in Barcelona. Conference foun...

S4-E24.4 - INCBCN Day 2 Summary

04 Jun 2023

Contributed by Lukas

Send a textSurfing NASH returns to review the 2023 Innovations in NAFLD Care Workshop (INCBCN) which concluded on 27 May in Barcelona. Conference foun...

S3-E24.3 - Focus on Preventative Hepatology

03 Jun 2023

Contributed by Lukas

Send a textSurfing NASH returns to review the 2023 Innovations in NAFLD Care Workshop (INCBCN) which concluded on 27 May in Barcelona. Conference foun...

S4-E24.2 - INCBCN Review: NAFLD and Social Drinking

03 Jun 2023

Contributed by Lukas

Send a textSurfing NASH returns to review the 2023 Innovations in NAFLD Care Workshop (INCBCN) which concluded on 27 May in Barcelona. Conference foun...

S4-E24.1 - INCBCN Review: NASH-NITs Real-World-Evidence Summit

03 Jun 2023

Contributed by Lukas

Send a textSurfing NASH returns to review the 2023 Innovations in NAFLD Care Workshop (INCBCN) which concluded on 27 May in Barcelona. Conference foun...

S4-E24 - Reviewing the 2023 Innovations in NAFLD Care Workshop

01 Jun 2023

Contributed by Lukas

Send a textSurfing NASH returns to review the second Innovations in NAFLD Care Workshop (INCBCN) which concluded on 27 May in Barcelona. Conference fo...

S4-E21.5 - From the Vault: ILC 2022 Looking Back: NASH Is a Complex Disease

28 May 2023

Contributed by Lukas

Send a textThe first three days of the 2022 program focused on a range of issues, with specific emphasis on non-invasive tests (NITs) and their role a...

S4-E21.4 - Virtual EASL Congress 2023 and the Power of Posters

28 May 2023

Contributed by Lukas

Send a textSurfing NASH offers an exciting preview of EASL Congress 2023 with new guest and EASL Vice-Secretary, Aleksander Krag, alongside EASL Educa...

S4-E21.3 - Curating the EASL 2023 Program and 3 “Can’t Miss” Features

28 May 2023

Contributed by Lukas

Send a textSurfing NASH offers an exciting preview of EASL Congress 2023 with new guest and EASL Vice-Secretary, Aleksander Krag, alongside EASL Educa...

S4-E21.2 - Previewing EASL Congress 2023: Highlighting Exciting Elements

28 May 2023

Contributed by Lukas

Send a textSurfing NASH offers an exciting preview of EASL Congress 2023 with new guest and EASL Vice-Secretary, Aleksander Krag, alongside EASL Educa...

S4-E21.1 Meeting Aleksander Krag and Setting the Stage for EASL Congress 2023

28 May 2023

Contributed by Lukas

Send a textSurfing NASH offers an exciting preview of EASL Congress 2023 with new guest and EASL Vice-Secretary, Aleksander Krag, alongside EASL Educa...

S4-E23.4 - Deep Dive into Hepatocellular Ballooning and the Power of AI

27 May 2023

Contributed by Lukas

Send a textStephen Harrison joins Louise Campbell and Roger Green for an insight-laden episode about challenges and opportunities in NASH drug develop...

S4-E23.3 - Lowering Screen Fail Rates and Guidelines for the Biopsy Reading Process

27 May 2023

Contributed by Lukas

Send a textStephen Harrison joins Louise Campbell and Roger Green for an insight-laden episode about challenges and opportunities in NASH drug develop...

S4-E23.2 - The Future of AI-Assisted Digital Pathology and NITs

27 May 2023

Contributed by Lukas

Send a textStephen Harrison joins Louise Campbell and Roger Green for an insight-laden episode about challenges and opportunities in NASH drug develop...

S4-E23.1 - Obeticholic Acid: Is the Juice Worth the Squeeze?

27 May 2023

Contributed by Lukas

Send a textStephen Harrison joins Louise Campbell and Roger Green for an insight-laden episode about challenges and opportunities in NASH drug develop...

S4-E23 - Stephen Harrison on Challenges and Opportunities in NASH Drug Development

25 May 2023

Contributed by Lukas

Send a textThis week on Surfing NASH, Stephen Harrison speaks with Louise Campbell and Roger Green about challenges and opportunities in NASH drug dev...

S4-E22 - PART 1: FDA ADCOM Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis Due to NASH

22 May 2023

Contributed by Lukas

Send a textOn Friday May 19, 2023, an Advisory Committee for the FDA convened to discuss the benefits and risks of obeticholic acid (OCA) 25 mg for tr...

S4-E21 - Surfing NASH Previews EASL Congress 2023

18 May 2023

Contributed by Lukas

Send a textSurfing NASH offers an exciting preview of EASL Congress 2023 with new guest and EASL Vice-Secretary, Aleksander Krag, alongside EASL Educa...

S4-E20.6 - From the Vault: Discussing NITs and Final Thoughts on NAFLD Summit

14 May 2023

Contributed by Lukas

Send a textThe 2022 NAFLD Summit presented a range of perspectives and insights on fatty liver and metabolic diseases. Program speakers Mazen Noureddi...

S4-E20.5 - Harnessing the Strengths of the Patient Advocate Community

14 May 2023

Contributed by Lukas

Send a textDonna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing n...

S4-E20.4 - Donna Cryer’s Call to Action for Patient Advocacy in the NASH Community

14 May 2023

Contributed by Lukas

Send a textDonna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing n...

S4-E20.3 - Generating and Promoting the Data to Demonstrate Patient Needs

13 May 2023

Contributed by Lukas

Send a textDonna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing n...

S4-E20.2 - Listening to Both Sides: Allied Health for Patient Empowerment

13 May 2023

Contributed by Lukas

Send a textDonna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing n...

S4-E20.1 - Who is going to be the Larry Kramer of NASH?

13 May 2023

Contributed by Lukas

Send a textDonna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing n...

S4-E20 - Leveraging Patient Voice and Needs in the NASH Community

11 May 2023

Contributed by Lukas

Send a textThis week, Donna Cryer (Global Liver Institute) joins Jörn Schattenberg, Louise Campbell and Roger Green for an impassioned and sobering e...

S4-E19.6 - From the Vault: REGENERATE Redux: Clearing The Finish Line?

07 May 2023

Contributed by Lukas

Send a textOn July 7 2022, Intercept Pharmaceuticals released new results from the continuation of the REGENERATE trial and announced their intent to ...

S4-E19.5 - Teasing the Difference Between Patient Advocate Voice and Patient Advocate Vote

07 May 2023

Contributed by Lukas

Send a textBack in March 2023, Jeff McIntyre (GLI) introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom ...

S4-E19.4 - Patient Advocates Describe the Reasoning Behind Their Testimonies

07 May 2023

Contributed by Lukas

Send a textBack in March 2023, Jeff McIntyre (GLI) introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom ...

S4-E19.3 - The Role of Biopsy in Prescribing NASH Therapeutics

06 May 2023

Contributed by Lukas

Send a textIn March 2023, Jeff McIntyre (GLI) introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and o...

S4-E19.2 - Patient Advocates React to the Word “Empathy”

06 May 2023

Contributed by Lukas

Send a textIn March 2023, Jeff McIntyre (GLI) introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and o...

S4-E19.1 - How Did the Patient Advocates Come to Offer Testimonies?

06 May 2023

Contributed by Lukas

Send a textIn March 2023, Jeff McIntyre (GLI) introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and o...

S4-E19 - Patient Advocate Panel Responds to ICER Draft Report on Resmetirom and Obeticholic Acid for NASH

04 May 2023

Contributed by Lukas

Send a textBack in March 2023, Jeff McIntyre (GLI) introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom ...

S4-E18.6 - From the Vault: Clinical Care Pathway: What Can Be Done Today?

30 Apr 2023

Contributed by Lukas

Send a textThe paper “Clinical Care Pathway for the Risk Stratification and Management of Patients with Nonalcoholic Fatty Liver Disease” is a cla...

S4-E18.5 - Allied Health Professionals and Patient Identification in Endocrinology Clinics

30 Apr 2023

Contributed by Lukas

Send a textAs part of our ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to foc...

S4-E18.4 - Empowering Physicians Through Simple Tools and the Demise of Beethoven

30 Apr 2023

Contributed by Lukas

Send a textAs part of our ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to foc...

S4-E18.3 - Positive Patient Engagement with Biofeedback and NAFLD/NASH in Chronic Kidney Patients

29 Apr 2023

Contributed by Lukas

Send a textAs part of our ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to foc...

S4-E18.2 - Risk Stratification and Identification of NAFLD/NASH Patients in the Endocrinology Setting

29 Apr 2023

Contributed by Lukas

Send a textAs part of our ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to foc...

S4-E18.1 - Meeting Cyrielle Caussy at the Intersection of Endocrinology and Hepatology

29 Apr 2023

Contributed by Lukas

Send a textAs part of our ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to foc...

S4-E18 - Interplay of Endocrinology and Hepatology in Treatment and Knowledge Development

27 Apr 2023

Contributed by Lukas

Send a textAs part of our ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to foc...

S4-E17.8 - Predictions for the Surfing NASH 6th Anniversary Special

23 Apr 2023

Contributed by Lukas

Send a textSurfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. The Big Band of Stephen Harrison,...

S4-E17.7 - Discussing the Drug Development Landscape and Growing Community Education

23 Apr 2023

Contributed by Lukas

Send a textSurfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. The Big Band of Stephen Harrison,...

S4-E17.6 - The Trajectory of Liver Science: How Far Have We Come?

22 Apr 2023

Contributed by Lukas

Send a textSurfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. The Big Band of Stephen Harrison,...

S4-E17.5 - Surfer Throwbacks: Meeting the Co-Hosts for the First Time

22 Apr 2023

Contributed by Lukas

Send a textSurfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. The Big Band of Stephen Harrison,...

S4-E17.4 - Stephen Harrison on Improving Clinical Trial Enrollment and Reminiscing on the Podcast’s Early Days

22 Apr 2023

Contributed by Lukas

Send a textSurfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. The Big Band of Stephen Harrison,...

S4-E17.3 - Surfing NASH 3rd Anniversary Special: Interview with Frédéric Cren of Inventiva Pharma

21 Apr 2023

Contributed by Lukas

Send a textThis week, Surfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. We are offering a jam-...

S4-E17.2 - Surfing NASH 3rd Anniversary Special: Interview with Donna Cryer of the Global Liver Institute

21 Apr 2023

Contributed by Lukas

Send a textThis week, Surfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. We are offering a jam-...

S4-E17.1 - Surfing NASH 3rd Anniversary Special: Interview with Amy Articolo of Novo Nordisk

21 Apr 2023

Contributed by Lukas

Send a textThis week, Surfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. We are offering a jam-...

S4-E17 - Surfing the NASH Tsunami 3rd Anniversary Special

19 Apr 2023

Contributed by Lukas

Send a textThis week, Surfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. We are offering a jam-...

S4-E16.6 - From the Vault: #NASHDay 2022: SurfingNASH Wrap-Up

16 Apr 2023

Contributed by Lukas

Send a textThursday, June 9, 2022 was the 5th International NASH Day (#NASHDay). Global Liver Institute, the largest liver patient advocacy organizati...

S4-E16.5 - How Do We Step Up to NASH?

16 Apr 2023

Contributed by Lukas

Send a textAs International #NASHDay 2023 approaches on June 8th, Surfing NASH dedicates a session to explore what makes this year’s occasion incred...

S4-E16.4 - #NASHDay and Activating Awareness Across Communities

16 Apr 2023

Contributed by Lukas

Send a textAs International #NASHDay 2023 approaches on June 8th, Surfing NASH dedicates a session to explore what makes this year’s occasion incred...

S4-E16.3 - The Untapped Potential of the Liver Community

15 Apr 2023

Contributed by Lukas

Send a textAs International #NASHDay 2023 approaches on June 8th, Surfing NASH dedicates a session to explore what makes this year’s occasion incred...